Compare NBY & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBY | NRC |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.6M | 390.8M |
| IPO Year | 2007 | 1997 |
| Metric | NBY | NRC |
|---|---|---|
| Price | $1.95 | $17.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 409.8K | 65.5K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.59% |
| EPS Growth | 35.42 | ★ 4707.69 |
| EPS | 0.76 | ★ 50.00 |
| Revenue | $370,000.00 | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.57 | ★ $0.36 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $0.43 | $9.76 |
| 52 Week High | $19.95 | $22.79 |
| Indicator | NBY | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 57.82 | 58.02 |
| Support Level | $1.01 | $16.64 |
| Resistance Level | $2.52 | $18.18 |
| Average True Range (ATR) | 0.26 | 0.75 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 96.45 | 74.85 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.